Worldwide inflation, ongoing effects of the COVID-19 pandemic and other macroeconomic factors continue to negatively impact established brands at a time when pharma companies need their positive cash flow the most to continue funding R&D.
Leading experts Ed Cox and Sean Rapson break down the facts and share their insight how to leverage new models like EVERSANA™ REIGNITE Commercialization, to properly invest in your established brands and maximize revenue potential.
Watch this 8 minute video or schedule a meeting with our experts. Or explore more information about Established Brands and our solutions.
Author
Sean brings experience gained through various internal commercial roles at a premier biopharmaceutical company and as a consultant advising leading biopharmaceutical clients. His focus is on defining and delivering corporate, portfolio, and brand-level vision…